AcrySof Toric Aspheric UV Absorbing IOL SA6AT3 (REF SA6AT3.270)Recalls & reported problems
Alcon Laboratories, Inc. · The AcrySof Aspheric UV Absorbing Toric Posterior Chamber Intraocular Lens (IOL) is a UV Absorbing foldable intraocular lens (IOL) · Class 3 · Implant
All models of AcrySof Toric Aspheric UV Absorbing IOL (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652335904), received between Mar 31, 2022 and Mar 31, 2022 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Blurred Vision1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 31, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NURSE REPORTED FOLLOWING AN INTRAOCULAR LENS IMPLANT PROCEDURE, THE PATIENT COULD NOT SEE WELL READING OR DISTANCE. NEAR VISION TARGET NOT NEAR ENOUGH FOR HER NEEDS. THE LENS WAS LATER EXCHANGED IN A SECONDARY PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED WHICH STATES THAT THIS LENS ISSUE WAS DISCOVERED (B)(6) 2021. PATIENT WAS A CONTACT LENS WEARER. SHE WAS A +2.00 HYPEROPE. SHE USED THIS LEFT EYE FOR NEAR FOR MONOVISION. WE CALCULATED FOR HER A RESIDUAL OF -1.88 WITH THE BARRETT FORMULA. SHE ENDED UP ONE MONTH POST OP ON (B)(6) 2021 WITH A REFRACTION OF PLANO-0.75X085 = 20/30. HER SURGERY WAS ROUTINE WITH NO COMPLICATIONS. THE LENS LOADED EASILY, OPENED EASILY IN THE EYE AND CENTERED WELL. POST OPERATIVELY SHE COMPLAINED OF DECREASED NEAR VISION. HER ORIGINAL K READINGS AVERAGE WAS 47.46 AND POST OP THREE MONTHS WAS 47.27 SO HER LACK OF NEAR VISION WAS NOT DUE TO A DRAMATIC CHANGE IN K READINGS. THE ISSUE THERE FOR WAS SIMPLY BETWEEN THE DESIRED AND ACHIEVED REFRACTIVE ERROR.
Patient problems: Blurred Vision
MAUDE report 13967111 ↗
Other intraocular lens devices
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens146 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens145 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens144 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens139 reports
- TECNIS SIMPLICITY DIB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens1 recall81 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens129 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens127 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens126 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page